Advanced search
Publication Cover
Nucleosides, Nucleotides & Nucleic Acids Volume 38, 2019 - Issue 5
Submit an article Journal homepage
192
Views
3
CrossRef citations to date
0
Altmetric
Articles

Artificial cationic peptides that increase nuclease resistance of siRNA without disturbing RNAi activity

Yusuke MaedaFaculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan; View further author information
,
Rintaro Iwata HaraFaculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan; ;Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan; ORCID Iconhttp://orcid.org/0000-0003-2399-3431View further author information
ORCID Icon,
Kazutaka NishinaDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan; View further author information
,
Kie Yoshida-TanakaDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan; View further author information
,
Taiichi SakamotoFaculty of Advanced Engineering, Chiba Institute of Technology, Narashino, Chiba, JapanView further author information
,
Takanori YokotaDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan; View further author information
&
Takeshi WadaFaculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7403-4033View further author information
ORCID Icon show all
Pages 338-348 | Received 02 Mar 2018, Accepted 29 Oct 2018, Published online: 19 Jan 2019

References

  • Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis elegans. Nature. 1998, 391, 806–811.
  • Leung, R. K. M.; Whittaker, P. A. RNA Interference: From Gene Silencing to Gene-Specific Therapeutics. Pharmacol. Ther. 2005, 107, 222–239.
  • Uprichard, S. L. The Therapeutic Potential of RNA Interference. FEBS Lett. 2005, 579, 5996–6007.
  • Pecot, C. V.; Calin, G. A.; Coleman, R. L.; Lopez-Berestein, G.; Sood, A. K. RNA Interference in the Clinic: challenges and Future Directions. Nat. Rev. Cancer. 2011, 11, 59–67.
  • Ghildiyal, M.; Zamore, P. D. Small Silencing RNAs: An Expanding Universe. Nat. Rev. Genet. 2009, 10, 94–108.
  • Bumcrot, D.; Manoharan, M.; Koteliansky, V.; Sah, D. W. RNAi Therapeutics: A Potential New Class of Pharmaceutical Drugs. Nat. Chem. Biol. 2006, 2, 711–719.
  • Soutschek, J.; Akinc, A.; Bramlage, B.; Charisse, K.; Constien, R.; Donoghue, M.; Elbashir, S.; Geick, A.; Hadwiger, P.; Harborth, J. Therapeutic Silencing of an Endogenous Gene by Systemic Administration of Modified siRNAs. Nature. 2004, 432, 173–178.
  • Rettig, G. R.; Behlke, M. A. Progress toward in Vivo Use of siRNAs-II. Mol. Ther. 2012, 20, 483–512.
  • Oh, Y. K.; Park, T. G. siRNA Delivery Systems for Cancer Treatment. Adv. Drug Deliv. Rev. 2009, 61, 850–862.
  • de Fougerolles, A. R. Delivery Vehicles for Small Interfering RNA in Vivo. Hum. Gene Ther. 2008, 19, 125–132.
  • Whitehead, K. A.; Langer, R.; Anderson, D. G. Knocking down Barriers: advances in siRNA Delivery. Nat. Rev. Drug Discov. 2009, 8, 129–138.
  • Romøren, K.; Thu, B. J.; Bols, N. C.; Evensen, Ø. Transfection Efficiency and Cytotoxicity of Cationic Liposomes in Salmonid Cell Lines of Hepatocyte and Macrophage Origin. Biochim. Biophys. Acta. 2004, 1663, 127–134.
  • Maeda, Y.; Iwata, R.; Wada, T. Synthesis and Properties of Cationic Oligopeptides with Different Side Chain Lengths That Bind to RNA Duplexes. Bioorg. Med. Chem. 2013, 21, 1717–1723.
  • Iwata, R.; Sudo, M.; Nagafuji, K.; Wada, T. Synthesis of Oligodiaminosaccharides Having α-Glycoside Bonds and Their Interactions with Oligonucleotide Duplexes. J. Org. Chem. 2011, 76, 5895–5906.
  • Iwata, R.; Nishina, K.; Yokota, T.; Wada, T. Synthesis and Properties of Double-Stranded RNA-Bindable Oligodiaminogalactose Derivatives Conjugated with Vitamin E. Bioorg. Med. Chem. 2014, 22, 1394–1403.
  • Iwata, R.; Nakayama, F.; Hirochi, S.; Sato, K.; Piao, W.; Nishina, K.; Yokota, T.; Wada, T. Synthesis and Properties of Vitamin E Analog-Conjugated Neomycin for Delivery of RNAi Drugs to Liver Cells. Bioorg. Med. Chem. Lett. 2015, 25, 815–819.
  • Endoh, T.; Ohtsuki, T. Cellular siRNA Delivery Using Cell-Penetrating Peptides Modified for Endosomal Escape. Adv. Drug Deliv. Rev. 2009, 61, 704–709.
  • Matsumoto, C.; Hamasaki, K.; Mihara, H.; Ueno, A. A High-Throughput Screening Utilizing Intramolecular Fluorescence Resonance Energy Transfer for the Discovery of the Molecules That Bind Hiv-1 Tar Rna Specifically. Bioorg. Med. Chem. Lett. 2000, 10, 1857–1861.
  • Chaloin, O.; Peter, J.-C.; Briand, J.-P.; Masquida, B.; Desgranges, C.; Muller, S.; Hoebeke, J. The N-Terminus of HIV-1 Tat Protein Is Essential for Tat-TAR RNA Interaction. Cell. Mol. Life Sci. 2005, 62, 355–361.
  • Varani, G.; Aboul-Ela, F.; Allain Progr, F. H. T. NMR Investigation of RNA Structure NMR. Spectr 1996, 29, 51–127.
  • Chou, S. H.; Flynn, P.; Reid, B.; Solid-Phase Synthesis and High-Resolution NMR Studies of Two Synthetic Double-Helical RNA Dodecamers: r(CGCGAAUUCGCG) and rCCGCGUAUACGCG). Biochemistry. 1989, 28, 2422–2435.
  • Haupenthal, J.; Baehr, C.; Kiemayer, S.; Zeuzem, S.; Piiper, A. Inhibition of RNAse a Family Enzymes Prevents Degradation and Loss of Silencing Activity of siRNAs in serumBiochem. Pharmacol. 2006, 71, 702–710.
  • Wang, Y.; Juranek, S.; Li, H.; Sheng, G.; Wardle, G. S.; Tuschl, T.; Patel, D. J. Nucleation, Propagation and Cleavage of Target RNAs in Argonaute Silencing Complexes. Nature 2009, 461, 754–761.
  • Plateau, P.; Gueron, M. Exchangeable Proton NMR without Base-Line Distorsion, Using New Strong-Pulse Sequences. J. Am. Chem. Soc. 1982, 104, 7310–7311.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.